Donate Now Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Boston Hotel

Aug 14, 2017 8:00 AM - Aug 15, 2017 3:30 PM

39 Dalton Street, , Boston, MA 02119 , USA

New Drug Product Development and Life Cycle Management

Back to Agenda

Module 2: Candidate Identification/Preclinical Testing

Session Chair(s)

Courtland R. LaVallee, MBA

Courtland R. LaVallee, MBA

Executive Director, Project Management

Dynavax Technologies, United States

Discovery
Drug Substance Scale up for Toxicology Testing
Simple Formulation for Phase 1 Clinical Work
Single Dose/MD Toxicity in Animals up to 14 or 30 Days
Development of Biomarkers for Phase 1
Summary

Have an account?